LigGrep: a tool for filtering docked poses to improve virtual-screening hit rates
- PMID: 33292486
- PMCID: PMC7656723
- DOI: 10.1186/s13321-020-00471-2
LigGrep: a tool for filtering docked poses to improve virtual-screening hit rates
Abstract
Structure-based virtual screening (VS) uses computer docking to prioritize candidate small-molecule ligands for subsequent experimental testing. Docking programs evaluate molecular binding in part by predicting the geometry with which a given compound might bind a target receptor (e.g., the docked "pose" relative to a protein target). Candidate ligands predicted to participate in the same intermolecular interactions typical of known ligands (or ligands that bind related proteins) are arguably more likely to be true binders. Some docking programs allow users to apply constraints during the docking process with the goal of prioritizing these critical interactions. But these programs often have restrictive and/or expensive licenses, and many popular open-source docking programs (e.g., AutoDock Vina) lack this important functionality. We present LigGrep, a free, open-source program that addresses this limitation. As input, LigGrep accepts a protein receptor file, a directory containing many docked-compound files, and a list of user-specified filters describing critical receptor/ligand interactions. LigGrep evaluates each docked pose and outputs the names of the compounds with poses that pass all filters. To demonstrate utility, we show that LigGrep can improve the hit rates of test VS targeting H. sapiens poly(ADPribose) polymerase 1 (HsPARP1), H. sapiens peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (HsPin1p), and S. cerevisiae hexokinase-2 (ScHxk2p). We hope that LigGrep will be a useful tool for the computational biology community. A copy is available free of charge at http://durrantlab.com/liggrep/ .
Keywords: Computational biology; Computer-aided drug discovery; Filters; Virtual screening.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
Gypsum-DL: an open-source program for preparing small-molecule libraries for structure-based virtual screening.J Cheminform. 2019 May 24;11(1):34. doi: 10.1186/s13321-019-0358-3. J Cheminform. 2019. PMID: 31127411 Free PMC article.
-
PLHINT: A knowledge-driven computational approach based on the intermolecular H bond interactions at the protein-ligand interface from docking solutions.J Mol Graph Model. 2018 Jan;79:194-212. doi: 10.1016/j.jmgm.2017.12.002. Epub 2017 Dec 6. J Mol Graph Model. 2018. PMID: 29241118
-
VSpipe-GUI, an Interactive Graphical User Interface for Virtual Screening and Hit Selection.Int J Mol Sci. 2024 Feb 7;25(4):2002. doi: 10.3390/ijms25042002. Int J Mol Sci. 2024. PMID: 38396680 Free PMC article.
-
Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets.J Cheminform. 2015 May 15;7:18. doi: 10.1186/s13321-015-0067-5. eCollection 2015. J Cheminform. 2015. PMID: 26082804 Free PMC article.
-
The use of protein-ligand interaction fingerprints in docking.Curr Opin Drug Discov Devel. 2008 May;11(3):356-64. Curr Opin Drug Discov Devel. 2008. PMID: 18428089 Review.
Cited by
-
Improvement of binding pose prediction of the MR1 covalent ligands by inclusion of simple pharmacophore constraints and structural waters in the docking process.3 Biotech. 2023 Aug;13(8):279. doi: 10.1007/s13205-023-03694-w. Epub 2023 Jul 19. 3 Biotech. 2023. PMID: 37483466 Free PMC article.
-
Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study.J Chem Inf Model. 2021 Sep 27;61(9):4758-4770. doi: 10.1021/acs.jcim.1c00744. Epub 2021 Sep 10. J Chem Inf Model. 2021. PMID: 34506150 Free PMC article.
-
Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M1 Antagonists.Pharmaceuticals (Basel). 2022 Feb 18;15(2):248. doi: 10.3390/ph15020248. Pharmaceuticals (Basel). 2022. PMID: 35215360 Free PMC article.
-
Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform.bioRxiv [Preprint]. 2025 May 23:2025.05.19.654757. doi: 10.1101/2025.05.19.654757. bioRxiv. 2025. PMID: 40475540 Free PMC article. Preprint.
-
Artificial intelligence unifies knowledge and actions in drug repositioning.Emerg Top Life Sci. 2021 Dec 21;5(6):803-813. doi: 10.1042/ETLS20210223. Emerg Top Life Sci. 2021. PMID: 34881780 Free PMC article. Review.
References
-
- Kontoyianni M. Docking and virtual screening in drug discovery. Methods Mol Biol. 2017;1647:255–266. - PubMed
-
- Varghese JN, Smith PW, Sollis SL, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL, Colman PM. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure. 1998;6:735–46. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials